Page 320 - AIDSBK23C
P. 320
Page 320
G, et al. Updated prevalence of genotypic resistance among HIV-1 positive patients naïve
to antiretroviral therapy: a single center analysis. J Med Virol. 2008;80:747-753.
278 Li JZ, Paredes R, Ribaudo HJ, Svarovskaia ES, Metzner KJ, Kozal MJ, Hullsiek KH, et
al. Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based
antiretroviral treatment failure: a systematic review and pooled analysis. JAMA.
2011;305:1327-1335.
279 Palella FJ Jr, Armon C, Buchacz K, Cole SR, Chmiel JS, Novak RM, Wood K, Moorman
AC, Brooks JT. The association of HIV susceptibility testing with survival among HIV-
infected patients receiving antiretroviral therapy: a cohort study. Ann Intern Med.
2009;151:135-136.
280 Perno CF, Moyle G, Tsoukas C, Ratanasuwan W, Gatell J, Schechter M. Overcoming
resistance to existing therapies in HIV-infected patients: the role of new antiretroviral
drugs. J Med Virol. 2008;80:565-576.
281 World Health Organization. Antiretroviral therapy.
http://www.who.int/hiv/topics/treatment/en (accessed April 6, 2010).
282 Josephson F, Albert J, Flamholc L, Gisslén M, Karlström O, Moberg L, Navér L, et al.
Treatment of HIV infection: Swedish recommendations 2009. Scand J Infect Dis.
2009;41:788-807.
283 Bozzette SA, Joyce G, McCaffrey DF, et al. Expenditures for the care of HIV-infected
patients in the era of highly active antiretroviral therapy. N Engl J Med. 2001;344:817-
823.
284 Silverberg MJ, Leyden W, Horberg MA, DeLorenze GN, Klein D, Quesenberry CP.
Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med.
2007;167:684-691.
285 Elston JW, Thaker H. Immune reconstitution inflammatory syndrome. Int J STD AIDS.
2009;20:221-224.
286 Tsang CS, Samaranayake LP. Immune reconstitution inflammatory syndrome after
highly active antiretroviral therapy: a review. Oral Dis. 2010;16:248-256.
287 Bell SK, Little SJ, Rosenberg ES. Clinical management of acute HIV infection: best
practice remains unknown. J Infect Dis. 2010;202 Suppl 2:S278-288.
